Skip to main content
Year archive

ONCOSIL MEDICAL LTD — 2020 filings

All 78 regulatory filings released by ONCOSIL MEDICAL LTD (OSL) in 2020, sourced directly from the official regulator.

78 Filings
2020 Period
2020 filings (78)
Filing Released Lang
Cancellation of shares under the Employee Share Plan 4 pages 210.9KB
Regulatory Filings
2020-12-17 English
Change of Director's Interest Notice 2 pages 229.2KB
Director's Dealing
2020-12-17 English
Change of Director's Interest Notice 2 pages 229.2KB
Director's Dealing
2020-12-17 English
Final Director's Interest Notice 2 pages 217.2KB
Director's Dealing
2020-12-17 English
Termination of Mr Daniel Kenny as Chief Executive Officer 2 pages 210.7KB
Board/Management Information
2020-12-01 English
OncoSil receives Swiss regulatory approval 2 pages 219.7KB
Regulatory Filings
2020-11-04 English
Appendix 2A 26 pages 367.9KB
Capital/Financing Update
2020-11-04 English
Change of Director's Interest Notice 2 pages 229.3KB
Director's Dealing
2020-11-04 English
Change of Director's Interest Notice 2 pages 229.8KB
Director's Dealing
2020-10-28 English
Change of Director's Interest Notice 2 pages 228.3KB
Director's Dealing
2020-10-26 English
OncoSil achieves first commercial sale 2 pages 302.1KB
Capital/Financing Update
2020-10-21 English
Appendix 4C - quarterly 9 pages 485.6KB
Interim / Quarterly Report
2020-10-20 English
2020 AGM Chairman's Address 2 pages 171.8KB
AGM Information
2020-10-19 English
2020 AGM CEO Presentation 11 pages 957.2KB
AGM Information
2020-10-19 English
Positive PanCO trial update on resected cohort 3 pages 318.3KB
Regulatory Filings
2020-10-19 English
Results of the OncoSil 2020 Annual General Meeting 2 pages 292.6KB
Declaration of Voting Results & Voting Rights Announcements
2020-10-19 English
Receipt of $2.8m R&D Tax Incentive Refund 2 pages 209.1KB
Capital/Financing Update
2020-09-22 English
2020 Notice of General Meeting & Proxy Form 30 pages 1.0MB
AGM Information
2020-09-17 English
OncoSil receives Malaysian regulatory approval 2 pages 253.3KB
Regulatory Filings
2020-08-27 English
Investor Update - Conference Call Notification 2 pages 214.7KB
Investor Presentation
2020-08-27 English
Investor Update 19 pages 1.3MB
Investor Presentation
2020-08-27 English
Appendix 4E and Annual Report 68 pages 3.2MB
Annual Report
2020-08-18 English
Preliminary Final Report - Appendix 4E Announcement 3 pages 285.4KB
Annual Report
2020-08-18 English
Appendix 4G and Corporate Governance Statement 17 pages 317.3KB
Governance Information
2020-08-18 English
Clarification of June Quarter Appendix 4C 1 page 14
Regulatory Filings
2020-08-06 English
Appendix 4C - quarterly 9 pages 487.0KB
Interim / Quarterly Report
2020-07-29 English
HDE filing submitted in US for Bile Duct Cancer treatment 2 pages 215.4KB
Regulatory Filings
2020-07-27 English
OncoSil presents clinical data at ESMO World Congress 4 pages 515.5KB
Investor Presentation
2020-07-02 English
OncoSil files for TGA registration 2 pages 219.6KB
Regulatory Filings
2020-07-01 English
Cancellation of shares under the Employee Share Plan 4 pages 209.7KB
Regulatory Filings
2020-06-29 English
Change of Director's Interest Notice 2 pages 238.8KB
Director's Dealing
2020-06-29 English
Change of Director's Interest Notice 2 pages 126.5KB
Director's Dealing
2020-06-29 English
OncoSil receives Singapore regulatory approval 2 pages 264.4KB
Regulatory Filings
2020-05-31 English
Appendix 3Y - Late Lodgement Notice - Daniel Kenny 4 pages 405.0KB
Director's Dealing
2020-05-28 English
Appendix 3Y - Late Lodgement Notice - Roger Aston 4 pages 585.1KB
Director's Dealing
2020-05-28 English
Change of Director's Interest Notice - Chris Roberts 2 pages 241.0KB
Director's Dealing
2020-05-28 English
Change in substantial holding - Daniel Kenny 2 pages 238.6KB
Director's Dealing
2020-05-28 English
Change of Director's Interest Notice - Martin Cross 2 pages 238.5KB
Director's Dealing
2020-05-28 English
Change of Director's Interest Notice - Michael Bassett 2 pages 239.4KB
Director's Dealing
2020-05-28 English
Change of Director's Interest Notice - Roger Aston 2 pages 238.6KB
Director's Dealing
2020-05-28 English
Change of Directors Interest Notice 2 pages 238.6KB
Director's Dealing
2020-05-28 English
Appendix 2A 14 pages 275.5KB
Capital/Financing Update
2020-05-27 English
Entitlement Offer Results and Shortfall Notification 2 pages 222.1KB
Capital/Financing Update
2020-05-25 English
Ceasing to be a substantial holder 7 pages 46.0KB
Major Shareholding Notification
2020-05-25 English
Ceasing to be a substantial holder 1 page 581.4KB
Major Shareholding Notification
2020-05-18 English
Becoming a substantial holder 7 pages 343.0KB
Major Shareholding Notification
2020-05-12 English
OncoSil Entitlement Offer Booklet 27 pages 479.1KB
Capital/Financing Update
2020-05-11 English
Becoming a substantial holder 2 pages 83.2KB
Major Shareholding Notification
2020-05-11 English
Allotment of Securities under Institutional Placement 2 pages 96.4KB
Capital/Financing Update
2020-05-07 English
Cleansing Notice 1 page 76.2KB
Capital/Financing Update
2020-05-07 English
Appendix 2A 14 pages 173.8KB
Regulatory Filings
2020-05-07 English
Ceasing to be a substantial holder 8 pages 328.6KB
Major Shareholding Notification
2020-05-07 English
OncoSil appoints Nigel Lange as EMEA President 3 pages 449.3KB
Board/Management Information
2020-05-03 English
OncoSil submits for ASEAN and APAC approvals 2 pages 217.1KB
Regulatory Filings
2020-05-03 English
OncoSil to present at Virtual Health Conference 2 pages 205.3KB
Investor Presentation
2020-05-03 English
OncoSil launches Capital Raising 5 pages 462.1KB
Capital/Financing Update
2020-05-03 English
Investor Presentation 37 pages 2.8MB
Investor Presentation
2020-05-03 English
Cleansing notice 3 pages 380.3KB
Capital/Financing Update
2020-05-03 English
Letter to ineligible shareholders 2 pages 120.3KB
Capital/Financing Update
2020-05-03 English
Proposed issue of Securities - OSL 10 pages 40.2KB
Capital/Financing Update
2020-05-03 English
Appendix 4C - quarterly 9 pages 487.6KB
Interim / Quarterly Report
2020-04-29 English
Trading Halt 2 pages 211.9KB
Capital/Financing Update
2020-04-28 English
Shares forfeited and cancelled 4 pages 200.6KB
Share Issue/Capital Change
2020-04-15 English
Ceasing to be a substantial holder 4 pages 185.4KB
Regulatory Filings
2020-04-06 English
Oncosil breakthrough device receives CE Marking approval 5 pages 229.7KB
Regulatory Filings
2020-03-31 English
Appointment of CFO and Company Secretary 2 pages 139.4KB
Board/Management Information
2020-03-30 English
Appendix 2A 28 pages 481.4KB
Share Issue/Capital Change
2020-03-26 English
Pause in Trading 1 page 110.3KB
Regulatory Filings
2020-03-26 English
Clarification Statement 2 pages 141.5KB
Regulatory Filings
2020-03-26 English
Appendix 2A 28 pages 485.7KB
Share Issue/Capital Change
2020-03-24 English
FDA Grants Breakthrough Device Designation 4 pages 190.9KB
Regulatory Filings
2020-03-17 English
Becoming and changing substantial holding 11 pages 491.3KB
Regulatory Filings
2020-03-17 English
Change of Director's Interest Notice 2 pages 587.3KB
Director's Dealing
2020-03-10 English
Half Yearly Report and Accounts 22 pages 461.4KB
Interim / Quarterly Report
2020-02-26 English
Ceasing to be a substantial holder 2 pages 89.1KB
Regulatory Filings
2020-02-20 English
Change in substantial holding 2 pages 137.1KB
Regulatory Filings
2020-02-17 English
Appendix 4C - quarterly 8 pages 319.8KB
Interim / Quarterly Report
2020-01-29 English
Change in substantial holding 6 pages 422.8KB
Major Shareholding Notification
2020-01-23 English